Morpholino

MO2-prnpb

ID

ZDB-MRPHLNO-100423-5

Name

MO2-prnpb

Previous Names

Target

Sequence

5' - GGTCCATAAAAAGGTTGAAGAAGCG - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

Targets 5'UTR.

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO2-prnpb

No data available

Phenotype

Phenotype resulting from MO2-prnpb

Phenotype	Fish	Figures
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules disrupted, abnormal	WT + MO2-prnpb	Fig. 5 from Málaga-Trillo et al., 2009
cell-cell adhesion disrupted, abnormal	WT + MO2-prnpb	Fig. 4 from Málaga-Trillo et al., 2009
DEL increased accumulation DEL cytoplasmic vesicle, abnormal	WT + MO2-prnpb	Fig. 6 from Málaga-Trillo et al., 2009
DEL adherens junction disorganized, abnormal	WT + MO2-prnpb	Fig. 6 from Málaga-Trillo et al., 2009
DEL cell circular, abnormal	WT + MO2-prnpb	Fig. 4 from Málaga-Trillo et al., 2009

1 - 5 of 7 Show all

Phenotype of all Fish created by or utilizing MO2-prnpb

Phenotype	Fish	Conditions	Figures
whole organism ab2-ctnnb labeling amount, ameliorated	WT + MO1-prnpb + MO2-prnpb	chemical treatment: N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	Fig. 1 , Fig. 4 from Sempou et al., 2016
endocytosis increased occurrence, abnormal	WT + MO1-prnpb + MO2-prnpb	control	Fig. 1 from Sempou et al., 2016
whole organism ab2-ctnnb labeling decreased amount, abnormal	WT + MO1-prnpb + MO2-prnpb	control	Fig. 1 , Fig. 4 from Sempou et al., 2016
epiboly arrested, ameliorated	WT + MO1-prnpb + MO2-prnpb	chemical treatment: chloroquine	Fig. 1 from Sempou et al., 2016
DEL cytosol ab2-ctnnb labeling mislocalised, abnormal	WT + MO1-prnpb + MO2-prnpb	control	Fig. 1 , Fig. 3 from Sempou et al., 2016

1 - 5 of 24 Show all

Citations

Include unpublished citations